[180 Pages Report] The Cannabis Market size was estimated at USD 32.73 billion in 2023 and expected to reach USD 41.77 billion in 2024, at a CAGR 28.29% to reach USD 187.24 billion by 2030.
The cannabis market products derived from cannabis include but are not limited to dry flowers, concentrates, edibles, topicals, and cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The cannabis industry serves various end-use sectors, such as healthcare, pharmaceuticals, personal care, and food & beverages. In the medical sector, cannabis is prescribed to alleviate symptoms associated with chronic pain, cancer, epilepsy, and multiple sclerosis, among others. The recreational use of cannabis provides an alternative to traditional leisure substances such as alcohol and tobacco. The scope of the cannabis market includes global and regional sales, product innovation, supply chain management, and regulatory landscapes. Cannabis market growth is predominantly driven by increasing legalization, growing medicinal applications, and the rising adoption of cannabis as a consumer good. Furthermore, advancements in genetics and cultivation technology, and increasing investment in cannabis-related research, contribute to the market's expansion. The latest potential opportunities within the cannabis market include the burgeoning CBD market, especially in the health and wellness sector, the integration of blockchain for supply chain transparency, and the exploration of new delivery systems to enhance bioavailability. Innovations are particularly thriving in areas of cannabis-infused products, such as beverages and edibles, as well as personalized cannabis medicines tailored to individual genetic profiles. Furthermore, implementing eco-friendly cultivation and processing methods to appeal to environmentally-conscious consumers and investing in consumer education to overcome stigma and inform about responsible use. Leveraging AI and machine learning for predictive analytics in cultivation and consumer preferences is expected to propel market growth. However, complex regulatory hurdles across different jurisdictions, high compliance costs, and the persistent stigmatization of cannabis use. In addition, the lack of standardized dosing and methods of consumption, significant competition from black-market operators, and hurdles in banking and financial services pose limitations to the market's potential.
Concentrated cannabis oils are highly potent extracts from cannabis plants. They contain concentrated levels of cannabinoids such as THC and CBD. These oils are utilized for a variety of applications, including vaping, dabbing, or as ingredients in edibles and topicals. Their high potency often means that smaller doses are required to achieve desired effects. Cannabis-infused creams are topical products designed for application on the skin. They are often used for localized relief of pain or inflammation and may also provide skincare benefits. These creams often combine CBD or THC with other therapeutic herbs and essential oils, and do not typically induce psychoactive effects. As food additives, cannabinoids such as THC and CBD can be incorporated into various food and beverage products. This form of consumption, known as edibles, allows for discrete and controlled dosing. Effects can take longer to onset when ingested, but typically last longer compared to other consumption methods. Inhaled liquids refer to products like CBD or THC vape juices that are designed to be used with electronic vaporizers or e-cigarettes. These products offer a smokeless alternative to traditional combustion methods, often preferred for their convenience, discreetness, and rapid onset of effects. These are encapsulated forms of cannabis extracts, designed to be taken orally. Similar to other dietary supplements, these capsules offer a convenient and precise dosing option with the added benefit of bypassing the plant's natural flavor. They are favored for their ease of use and portability. Tincture sprays are alcohol or oil-based cannabis extracts offered in small, discreet bottles with a spray nozzle. They are typically applied under the tongue, providing rapid absorption into the bloodstream. This sublingual method allows for quick onset of effects, precise dosing, and easy use.
Cannabis concentrates are products created by the accumulation of trichomes, the most potent parts of the cannabis plant. These trichomes contain high levels of cannabinoids and terpenes. Concentrates come in various forms such as hash, shatter, wax, and oils, and are often used for their increased potency and for the different methods by which they can be consumed, including vaporization and dabbing. The cannabis flower is the classic form of cannabis and refers to the smokable part of the plant, which has been dried and cured. Flowers are appreciated for their natural terpene profiles and range of cannabinoids. They are commonly used in traditional smoking methods, such as in hand-rolled joints or through pipes and bongs. While not as potent as the flower, cannabis leaves can also be utilized in various ways. The leaves, especially those that are trimmed during the cultivation process, may contain some cannabinoids, and can be used to make edibles or teas. However, they are not typically smoked due to their lower potency compared to the flower. Cannabis seeds are primarily used for cultivation to grow new cannabis plants. Though they do not contain THC and will not produce psychoactive effects, they are vital for the reproduction and the genetic diversification of cannabis strains. In addition to cultivation, hemp seeds - a variety of Cannabis sativa - are also consumed for their nutritional benefits and can be found in health food products.
Cannabis strains with a balanced concentration of THC and CBD are known for providing a middle ground between CBD-dominant and THC-dominant profiles. This balance can offer a synergistic interaction known as the "entourage effect," which may enhance the therapeutic benefits while mitigating potential side effects. Consumers often report a moderate psychoactive experience along with the calming effects of CBD, making these strains suitable for various medical conditions and lifestyle uses. CBD-dominant cannabis varieties possess a higher concentration of Cannabidiol compared to THC. This profile is sought after for its non-intoxicating properties and potential therapeutic benefits, such as anti-inflammatory, analgesic, and anxiolytic effects. CBD-dominant strains are particularly popular among users seeking relief from symptoms without the pronounced psychoactive effects commonly associated with THC. THC-dominant cannabis strains are characterized by high levels of Tetrahydrocannabinol, the primary psychoactive component of cannabis. These strains are favored for their potent psychoactive effects, which may include euphoria, altered perception, and cognition, and increased appetite. Medical consumers may use THC-dominant strains for conditions such as chronic pain, insomnia, and to combat nausea and vomiting induced by chemotherapy.
The offline distribution of cannabis involves brick-and-mortar locations such as dispensaries, cannabis retail stores, and pharmacies where medicinal marijuana is sold. These physical outlets are highly regulated and operators must comply with state and local laws, which typically mandate security measures, product testing, and tracking. Consumers benefit from direct interactions with knowledgeable staff, the ability to inspect products, and immediate purchases. Additionally, some regions may allow for the operation of cannabis cafes or lounges where consumers can purchase and consume products on-site. Online cannabis distribution channels have been growing rapidly, embracing the shift towards e-commerce. Consumers in areas where cannabis is legal can order products from websites or mobile apps of licensed retailers or directly from producers where regulations permit. This mode of distribution offers convenience, privacy, and a wider range of product selections. In addition, online channels provide platforms for consumers to view lab reports, reviews, and detailed product information before making a purchase. Compliance with laws for age verification and delivery are critical elements in the online cannabis sales process.
Cannabis, particularly hemp-derived cannabidiol (CBD), has gained significant traction in the cosmetics and personal care industry. These compounds are incorporated into a variety of products such as moisturizers, serums, balms, and oils, due to their alleged anti-inflammatory, antioxidant, and anti-aging properties. As consumers increasingly seek natural and organic personal care options, the inclusion of cannabis extracts in formulations is expected to expand further, driving growth in this market segment. The infusion of cannabis, specifically non-psychoactive CBD, into food and beverages has emerged as a growing trend within the industry. CBD is often added to a range of products, including but not limited to, chocolates, gummies, teas, and non-alcoholic drinks, attributing wellness and relaxation benefits to these edibles and drinkables. Regulatory considerations remain a critical factor for market players, as laws differ widely concerning the addition of cannabis compounds to consumable products. In the realm of medical and pharmaceuticals, cannabis has a well-established presence, particularly for its use in pain management, treatment of epilepsy, and for its potential in alleviating symptoms associated with chemotherapy. THC and CBD, the principal psychoactive and non-psychoactive components of cannabis, respectively, are the focus of extensive research for their therapeutic properties and in the development of prescription drugs. The pet care industry has started to explore the benefits of cannabis-based products for animals. CBD, in particular, is utilized in products aimed at reducing anxiety, pain, and seizure occurrences in pets, mirroring many applications in human healthcare. The pet cannabis market is expected to grow, but it will also have to navigate a complex regulatory environment and establish standardized dosing and safety guidelines. Recreational cannabis represents a significant segment where the legal consumption of cannabis products, such as flowers, edibles, concentrates, and topicals, is intended for enjoyment rather than medical necessity. This application is among the most visible and widely known in jurisdictions where cannabis use has been decriminalized or legalized. As the legal market expands, it is increasingly characterized by a broad product range, sophisticated branding, and regulated distribution channels, all of which contribute to displacing illicit markets and promoting safe use practices.
The Americas represents a complex and rapidly expanding cannabis market, differing minimally at the federal level but with nuanced legal frameworks across the states. Consumer needs vary significantly by region and demographics, with trends showing a substantial increase in demand for both medicinal and, in legal states, recreational cannabis products. Customer purchasing behavior demonstrates a strong inclination towards edibles and vapes. Several states have initiated research programs while the race for new patents is intense, particularly in cultivation tech and cannabinoid synthesis. In APAC, China’s and India's involvement in the cannabis market is predominantly focused on the production of hemp, a non-psychoactive variety of cannabis. China is one of the largest producers of hemp-derived products such as textiles and cannabidiol (CBD) extracts, though consumption within the country remains strictly controlled. Meanwhile, India presents a nascent market with ancient cultural ties to cannabis, and while still heavily regulated, it shows potential for medical cannabis research and Ayurvedic applications. In Europe, the regulatory landscape for cannabis is fragmented but generally moving towards more open medicinal markets, with countries such as Germany, Italy, and the Netherlands leading in patient access and product diversity. The EU's customer purchasing behavior reflects a growing awareness and acceptance of the potential medical benefits of cannabis, leading to increased investment in pharmaceutical cannabis products and related research.
The FPNV Positioning Matrix is pivotal in evaluating the Cannabis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cannabis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Organigram Announces USD 92.91 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool
Organigram Holdings Inc. announced a significant USD 92.91 million equity investment from BT DE Investments Inc., a subsidiary of British American Tobacco. This strategic infusion of capital represents a powerful endorsement from a leading consumer goods company and is poised to fast-track Organigram's growth trajectory. With the investment, named "Jupiter," Organigram aims to expand its reach, enhance its technological capabilities, and diversify its product offerings. The initiative further cements the already robust partnership with BAT, tapping into their expansive global resources and scientific prowess for shared progressive ventures. [Published On: 2023-11-06]
Tilray Closes Acquisition of Hexo Corp To Create ‘Largest Canadian Cannabis Company by Revenue’
Tilray, Inc. has effectively concluded its acquisition of Hexo Corp, solidifying its position as the preeminent Canadian cannabis company based on revenue. This strategic move bolsters the firm's competitiveness against Canopy Growth Corporation, positioning it for market leadership. Additionally, the integration is set to drive significant operational efficiencies, with anticipated annual cost savings of USD 27 million. In the mechanics of the deal, Tilray issued approximately 19.5 million common shares, granting former Hexo shareholders 0.4352 of a Tilray share for each Hexo share held, leading to the cessation of Hexo's stock trading. [Published On: 2023-06-26]
Curaleaf Completes Acquisition of Deseret Wellness
Curaleaf Holdings, Inc. has successfully finalized its acquisition of Deseret Wellness, Utah's foremost cannabis retailer. This strategic move significantly bolsters Curaleaf's presence in the burgeoning Utah market, expanding their local dispensary count to four and extending the company's reach to an impressive 150 retail locations throughout the United States. The integration of Deseret Wellness under the Curaleaf banner marks yet another milestone in the company's expansion, highlighting its commitment to growth and leadership in the nation's competitive cannabis industry. [Published On: 2023-04-10]
The report delves into recent significant developments in the Cannabis Market, highlighting leading vendors and their innovative profiles. These include Acreage Holdings, Aphria, Inc., Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Chronos Group Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., CV Sciences Inc., EcoGen Biosciences, Elixinol Wellness Limited, Extractas Bioscience, Folium Europe B.V., Green Thumb Industries Inc., Lexaria Bioscience Corp., Medical Marijuana, Inc., MediPharm Labs Inc., Organigram Holdings Inc., Peace Naturals Project Inc., PharmaHemp d.o.o., StenoCare A/S, The Seed Cellar, and Tikun Olam.
This research report categorizes the Cannabis Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Form
- Concentrated Oil
- Cream
- Food Additive
- Inhaled Liquids
- Supplement Capsule
- Tincture Spray
- Product Type
- Concentrates
- Flower
- leaves
- Seeds
- Compound
- Balanced THC & CBD
- Cannabidiol (CBD)-Dominant
- Tetrahydrocannabinol (THC)-Dominant
- Source
- Non-Organic
- Organic
- Distribution Channel
- Offline
- Online
- Application
- Cosmetics & Personal Care
- Food & Beverage
- Medical & Pharmaceuticals
- Pet Care
- Recreational
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Cannabis Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cannabis Market?
- What are the technology trends and regulatory frameworks in the Cannabis Market?
- What is the market share of the leading vendors in the Cannabis Market?
- Which modes and strategic moves are suitable for entering the Cannabis Market?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Cannabis Market, by Form
- Cannabis Market, by Product Type
- Cannabis Market, by Compound
- Cannabis Market, by Source
- Cannabis Market, by Distribution Channel
- Cannabis Market, by Application
- Americas Cannabis Market
- Asia-Pacific Cannabis Market
- Europe, Middle East & Africa Cannabis Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 28]
- List of Tables [Total: 564]
- List of Companies Mentioned [Total: 23]
On June 9, 2022, cannabis plant parts were entirely removed from Thailand's narcotic list decriminalizing all cannabis-related crimes. Consumers waited in line at stores that sold cannabis-infused beverages, candies, and other goods to welcome the change in a nation known for having strict drug regulations.
The government has launched a campaign to give away a million plants, encouraging farmers to cultivate cannabis as a commercial crop. Thailand's focus on medical tourism also has the potential to significantly boost sales of cannabidiol (CBD) products, including medicines, candles, and massage oils.
Thailand's marijuana and hemp business draw interest from large and small companies in the country, attracting nearly 1 billion baht (about USD 35 million) of investment to become the regional manufacturing hub of CBD products, exporting goods to Japan, Australia, and Europe. In 2021, the Tobacco Authority of Thailand (TOAT) announced a plan to transition 13,500 tobacco farmers to industrial hemp and marijuana, suggesting growers could nearly triple their income by cultivating cannabis.
Globally, companies are creating diverse platforms to ship marijuana products by investing in blockchain and automation technologies. The incorporation of artificial intelligence and machine learning in cannabis cultivation is also transforming the cannabis industry worldwide.
Cannabis for Neurological Disorders:
Neurological disorders are a group of diseases affecting the nervous system, including the brain, spinal cord, and nerves. These disorders can cause severe symptoms, such as seizures, tremors, and muscle spasms. Cannabis has shown significant improvements in the symptoms of patients diagnosed with neurological disorders like epilepsy, Parkinson's disease, multiple sclerosis, and Alzheimer's disease. The cannabinoids present in cannabis act as a natural anti-inflammatory and antioxidant, which helps to reduce inflammation in the nervous system, leading to a reduction in symptoms.
Cannabis for Chronic Pain:
Chronic pain is a long-term condition that affects millions of people worldwide. It can be caused by various health conditions like arthritis, fibromyalgia, and migraines. Cannabis-based products like CBD oil and tinctures have shown significant improvements in the management of chronic pain. The cannabinoids present in cannabis reduce the sensation of pain by interacting with the brain's receptors. Furthermore, cannabis also reduces inflammation and enhances the body's natural pain-relieving systems.
Cannabis for Anxiety and Depression:
Anxiety and depression are mental health concerns that affect millions of people globally. Traditional medications for anxiety and depression come with severe side effects, leading to seeking alternative treatments like cannabis. Cannabis has shown great potential in the treatment of anxiety and depression owing to its calming and mood-boosting effects. The cannabinoids interact with the receptors in the brain, leading to a reduction in anxiety and an enhancement in mood.
Cannabis for Cancer Treatment:
Cancer is one of the major causes of mortality worldwide, and various treatments come with severe side effects, pushing several patients to seek alternative treatments like cannabis. Cannabis-based products like CBD oil and tinctures have shown significant improvements in the management of cancer treatment side effects like pain, nausea, and loss of appetite. Furthermore, cannabis has shown great potential in the treatment of the symptoms of cancer itself, like tumor growth and metastasis.
Cannabis is becoming an essential treatment option for patients diagnosed with neurological disorders and other chronic diseases. The increase in cannabis use in healthcare has paved the way for numerous studies and research, showing the potential benefits of cannabis in treating various health conditions. Furthermore, with the legalization of cannabis, more patients are gaining access to it as an alternative treatment option to traditional medications. The future of cannabis in the field of medicine and healthcare is promising, and with more research, it may become a primary treatment option for various diseases.
- How big is the Cannabis Market?
- What is the Cannabis Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?